Top Markets
Coin of the day
Nextgen Biomed Ltd Nextgen Biomed Ltd

Nextgen Biomed Ltd

NXGN
Clasificación en acciones #37893
Nextgen Biomed Ltd focuses on developing external dermatological treatments for... Nextgen Biomed Ltd focuses on developing external dermatological treatments for psoriasis. The company, which was established in 1990, originally operated under the name Sela Group.Com Ltd. before rebranding as Nextgen Biomed Ltd in February 2010. Its operations are headquartered in Tel Aviv, Israel.
Precio por acción
$0.14896012
Última sincronización: 2026-02-16
Capitalización bursátil
$1.37M
Cambio (1 día)
-2.89%
Cambio (1 año)
-19.65%
País
IL
Comercio Nextgen Biomed Ltd (NXGN)

Categoría

Ganancias de Nextgen Biomed Ltd (NXGN)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Nextgen Biomed Ltd, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Nextgen Biomed Ltd desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$3.81B -
US
$4.11B -
FR
- -
JP
$1.59B -
US
- -
CH